CMP: 302

Ajanta Pharma Limited is a pharmaceutical company involved in the areas of product research, manufacturing, and marketing. The Company's manufacturing capabilities include segments such as antiretrovirals, antimalarials, cardiovascular, dermatology, and ophthalmology. The Company also markets over the counter products that include some nature-based remedies.

Ajanta Pharma is a good bet in small-cap pharma space. Its currently trading at a P/E of less than 7 with good dividend yields of close to 2% in the last 12 months. It currently runs at a debt of 158 Crores which puts debt to profit ratio above 3. They currently have cash in hand of over 13 Crores. Revenues have risen from 239 Crores to 457 Crores in the last 5 years. Profits have risen from 14 Crores to 46 Crores in the last 5 years. NPM has risen significantly from less than 6% to over 10% in the last 5 years. Buy and hold for long term gains.